2015
DOI: 10.1016/j.ejmech.2014.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis and evaluation of small molecule imidazo[2,1-b][1,3,4]thiadiazoles as inhibitors of transforming growth factor-β type-I receptor kinase (ALK5)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
27
0
2

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(29 citation statements)
references
References 19 publications
0
27
0
2
Order By: Relevance
“…In TGF‐β signalling, Smad2 or Smad3 binds to its specific TGF‐β receptor I, named ALK5, and is phosphorylated by the catalytic region of ALK5 . Based on our data described above, we then hypothesized that baicalein bound directly to the catalytic region of ALK5 to inhibit phosphorylation of Smad2 and Smad3.…”
Section: Resultsmentioning
confidence: 91%
See 2 more Smart Citations
“…In TGF‐β signalling, Smad2 or Smad3 binds to its specific TGF‐β receptor I, named ALK5, and is phosphorylated by the catalytic region of ALK5 . Based on our data described above, we then hypothesized that baicalein bound directly to the catalytic region of ALK5 to inhibit phosphorylation of Smad2 and Smad3.…”
Section: Resultsmentioning
confidence: 91%
“…Researchers have shown an affinity between a variety of small molecules and the ATP-binding site of ALK5, and such an interaction has been found to be associated with downregulated TGF-b signalling. 24,35,43 In light of this, we performed a molecular docking study and kinase binding assay in search of an interaction between baicalein and ALK5. Intriguingly, it was validated in our study that baicalein bound to the ATPbinding pocket of ALK5 through two hydrogen bonds in different directions.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Among the most commonly used heterocyclic compounds in pharmaceutics and clinical drugs are imidazole, 1,3,4‐thiadiazole, and their derivatives. In recent years, synthesis and characterization studies of bioactive compounds such as imidazole and 1,3,4‐thiadiazole have been steadily increasing . The synthesis of compounds containing these bioactive groups together with various biological activities has received much interest as well .…”
Section: Introductionmentioning
confidence: 99%
“…If a compound fails in this test, it is likely that some oral bioavailability problem will be encountered. 29 According to the RO5, the compounds should present logP ≤ 5, molecular weight ≤ 500, number of hydrogen bond acceptors (n ON ) ≤ 10, number of hydrogen bond donors (n OHNH ) ≤ 5, and number of rotatable bonds (n rotb ) ≤ 10, wherein compounds should not violate more than one rule. In this sense, molecules A, B and C were constructed in the Molinspiration Online Property Calculation Software Toolkit 30 for the evaluation of the Lipinski's Rule.…”
mentioning
confidence: 99%